Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-08

Clinical Trial Update: Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing thyrotropin-releasing hormone in healthy volunteers and patients with thyroid or pituitary abnormalities; study status complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thyrotropin-releasing hormone (thyrotropin-releasing hormone)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Healthy, Pituitary Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-08-08